[an error occurred while processing this directive] ����Ƥ���Բ�ѧ��־ 2009, 35(5) 300-302 DOI:     ISSN: 2096-5540 CN: 32-1880/R

����Ŀ¼ | ����Ŀ¼ | ������� | �߼�����                                                            [��ӡ��ҳ]   [�ر�]
����
��չ����
������Ϣ
Supporting info
PDFȫ��
[HTMLȫ��]
�����
�����뷴��
�ѱ����Ƽ�������
�����ҵ����
�������ù�����
����
Email Alert
���·���
���������Ϣ
���Ĺؼ����������
ϵͳ��ӲƤ�����ζ�����ѹ����ϣ�����
���������������
����
����
�ィ��
PubMed
Article by Li,X.J
Article by Zhang,l
Article by Xun,J.P

ϵͳ��ӲƤ����طζ�����ѹ

��С��1,����2,�ィ��3

1. �й�ҽѧ��ѧԺƤ�����о���
2. �й�ҽѧ��ѧԺ�Ͼ�Ƥ�����о��������
3. �Ͼ� �й�ҽѧ��ѧԺ����Э��ҽѧԺƤ�����о���

ժҪ��

�β���ϵͳ��ӲƤ����ۼ�������֮һ����ΪӲƤ��������������Ҫԭ�򣬷ζ�����ѹ������ϵͳ��ӲƤ����һ��ԭ�����ٴ����֣�Ҳ���Լ̷��ڼ����Է���ά����ϵͳ��ӲƤ����طζ�����ѹ���ڿ����κ�֢״��֢״�����ԣ���Ͻ����ѣ����ι��ܲⶨ�ɷ���������ɢ�����ϰ�����ˣ���ʶϵͳ��ӲƤ����طζ�����ѹ��Σ�����ؼ�����������̣�������ʶ����ϼ���һ���Ż����Ʒ�����

�ؼ����� ϵͳ��ӲƤ�����ζ�����ѹ����ϣ�����  

Pulmonary arterial hypertension associated with systemic scleroderma

Abstract:

Lung is a most commonly involved organ in systemic scleroderma ��SS��. As a predominate reason for the death of patients with SS, pulmonary hypertension may be a primary manifestation of SS or a secondary manifestations following interstitial pulmonary fibrosis. It is difficult to diagnose pulmonary hypertension at early stage since symptoms may be absent or just unobvious in patients, while pulmonary function test, which can reveal gas diffusion dysfunction at early stage, may benefit the early diagnosis of it. To understand the risk factors and pathogenesis of SS-associated pulmonary hypertension may facilitate the early recognization, diagnosis, and optimization of treatment of this entity.

Keywords:
�ո����� 2009-02-20 �޻����� 2009-03-23 ����淢������ 2009-09-11 
DOI:
������Ŀ:

��;ʡ����Ȼ��ѧ������Ŀ

ͨѶ����: ��С��
���߼��:

�ο����ף�
�������������

�������� (��ע��:��վʵ�������Ը�, �벻Ҫ������ѧ���޹ص�����!�������ݲ�����վ�۵�.)

Copyright 2008 by ����Ƥ���Բ�ѧ��־